Neuroprostheses electrically stimulate paralyzed muscles to provide functional enhancement for individuals with neurological disorders, especially among persons with spinal cord injuries. Fully implanted neuroprostheses are reliable, require minimal maintenance and are user-friendly. These systems provide a variety of functions, including reaching, hand grasp and release, standing and stepping, bladder and bowel function and respiratory assist. Based on a representative review of the literature, this article presents and evaluates the development, clinical implementation and clinical efficacy and effectiveness of the various implanted neuroprostheses. Directions for future development are also presented. Press and the authors. All rights reserved N. Bhadra and J. Chae / Implantable neuroprosthetic technology Table 1 Key publications in implanted neuroprostheses Topic Author/year Article summary Review Ragnarsson [88], 2008 An overview of the progress made in FES applications, current challenges and suggested future improvements. DiMarco [32], 2005 A review of Functional Electrical Stimulation (FES) technology for restoration of respiratory function. Upper Limb Peckham [82], 2001 A multicenter cohort trial of an implanted hand neuroprosthesis for persons with tetraplegia with at least 3 years of follow-up. Hand function of 51 adults with C5 or C6 spinal cord injury (SCI) was compared before and after implantation, and with and without the neuroprosthesis. The neuroprosthesis was safe and well accepted, and increased independence. Lower Limb Kottink [70], 2007 A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator among 29 stroke chronic stroke survivors. The intervention group received the implantable stimulator for correction of drop foot. The control group used conventional walking devices (ankle-foot orthosis, orthopedic shoes, or no device). FES resulted in a 23% improvement in walking speed, whereas the improvement in the control group was 3%. The study showed a clinically relevant effect of the implantable stimulator on walking speed. Bladder Brindley [16], 1994 A review of the first 500 patients implanted with a sacral anterior root stimulators for bladder control. Of 479 survivors, 424 were using their stimulators when last followed up between 3 months and 16.1 years (mean 4 years) after implantation. Creasey [27], 2001A prospective study comparing bladder and bowel control before and at 3, 6, and 12 months after implantation of a neuroprosthesis for stimulating the sacral nerves with posterior sacral rhizotomy among 23 individuals with suprasacral SCI. At 1-year follow-up, 18 of 21 patients could urinate more than 200 mL with the neuroprosthesis; fifteen of 21 had post void volumes of less than 50 mL. The incidence of urinary tract infections, catheter use, reflex incontinence, anticholinergic drug use, and autonomic dysreflexia were substantially reduced at follow-up relative to pre-implantation. At 1-year follow-up, 15 of 17 patients reduced the time spent with bowel managem...